GPC1 and pancreatic neoplasm: In a study by Melo et al., GPC1(+) circulating exosomes were detected in all enrolled 190 pancreatic cancer patients, with 100% sensitivity and 100% specificity, and from early stages, indicating that it might be a potent early screening biomarker in pancreatic cancer [24].